PORTRAZZA™ is an epidermal growth factor receptor (EGFR) antagonist indicated, in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic squamous non-small cell lung cancer.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of PORTRAZZA (necitumumab) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the PORTRAZZA (necitumumab) injection medicine cost price in India.
The order for PORTRAZZA (necitumumab) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Necitumumab (INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic. It binds to the epidermal growth factor receptor (EGFR). The US FDA approved necitumumab under the brand name Portrazza for use with gemcitabine and cisplatin in previously untreated metastatic squamous non-small-cell lung carcinoma (NSCLC). It was counterproductive in non-squamous non-small-cell lung carcinoma.
PORTRAZZA (necitumumab) injection, for intravenous use Initial U.S. Approval: 2015
Generic Name: necitumumab
Injection: 800 mg/50 mL (16 mg/mL) solution in a single-dose vial.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand PORTRAZZA (necitumumab) injection on prescription and Import License in Patient's Name only.
For overseas patients, PORTRAZZA (necitumumab) injection can be made available in Send your enquiry to find PORTRAZZA (necitumumab) injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For PORTRAZZA (necitumumab) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Lilly wins European approval for lung cancer drug Portrazza For More Details
Necitumumab (Portrazza) Approved for Lung Cancer in US For More Details